AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue


Page 43 of 43

Source Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, Dearani JA, Epps-Anderson KC, Evanovich L, Ferrari VA, Joglar JA, Khan SS, Kim JJ, Kittleson MM, Krittanawong C, Martinez MW, Mital S, Naidu SS, Saberi S, Semsarian C, Times S, Waldman CB. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. [published online ahead of print May 08, 2024]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2024.02.014 Copublished in Circulation. doi: 10.1161/CIR.0000000000001250. Abbreviations AF, atrial fibrillation; CAD, coronary artery disease; CMR, cardiovascular magnetic resonance; CPET, cardiopulmonary exercise test; CRT, cardiac resynchronization therapy; DOAC, direct-acting oral anticoagulants; EF, ejection fraction; ESM, extended septal myectomy; GDMT, guideline-directed management and therapy; HCM, hypertrophic cardiomyopathy; HF, heart failure; ICD, implantable cardioverter-defibrillator; LBBB, le bundle branch block; LGE, late gadolinium enhancement; LV, le ventricular; LVAD, le ventricular assist device; LVEF, le ventricular ejection fraction; LVH, le ventricular hypertrophy; LVOT, le ventricular outflow tract; LVOTO, le ventricular outflow tract obstruction; MET, metabolic equivalent; MR, mitral regurgitation; NSVT, non-sustained ventricular tachycardia; NYHA, New York Heart Association; RCT, randomized controlled trial; RV, right ventricular; SAM, systolic anterior motion; SCAF, subclinical atrial fibrillation; SCD, sudden cardiac death; SRT, septal reduction therapy; TdP, torsades de pointes; TEE, transesophageal echocardiogram; TTE, transthoracic echocardiogram; VF, ventricular fibrillation; VT, ventricular tachycardia; VUS, variant of uncertain significance Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. AHAHCM04243b TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2024 All rights reserved GuidelineCentral.com

Articles in this issue

Links on this page

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024